Home › Funds › Divisadero Street Capital Management, LP › BBNX
Divisadero Street Capital Management, LP position in BBNX
BETA BIONICS INC · Health Care
Divisadero Street Capital Management, LP reported holding 1,113,802 shares of BBNX (BETA BIONICS INC) in its Q2 2026 13F filing — a position valued at US$17.5M, representing 0.43% of its reported portfolio and ranking #44 among its reported holdings. Divisadero Street Capital Management, LP has disclosed BBNX holdings in 3 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Divisadero Street Capital Management, LP's BBNX position evolved
Divisadero Street Capital Management, LP first disclosed a stake in BBNX in Q2 2025 at 948,965 shares (US$13.8M). The position peaked in Q2 2026 at 1,113,802 shares, worth US$17.5M. Across 3 filings, Divisadero Street Capital Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,113,802 shares valued at US$17.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 948.97K | $13.82M | New |
| Q4 2025 | 39.61K | $1.21M | New |
| Q2 2026 | 1.11M | $17.45M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBNX and 13F data
BBNX (BETA BIONICS INC) is a Health Care company. 52 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$98.1M), Soleus Capital Management, L.P. (US$68.8M), Sands Capital Alternatives, LLC (US$58.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBNX
- EVENTIDE ASSET MANAGEMENT, LLC 6.25M sh · $98.05M · Q2 2026
- Soleus Capital Management, L.P. 4.39M sh · $68.85M · Q2 2026
- Sands Capital Alternatives, LLC 3.71M sh · $58.11M · Q2 2026
- Vestal Point Capital, LP 1.60M sh · $25.07M · Q2 2026
- Omega Fund Management, LLC 1.32M sh · $20.62M · Q2 2026
- Eversept Partners, LP 1.25M sh · $19.58M · Q2 2026
- Bruce & Co., Inc. 665.70K sh · $10.43M · Q2 2026
- Tri Locum Partners LP 493.34K sh · $7.73M · Q2 2026
- PURA VIDA INVESTMENTS, LLC 281.16K sh · $4.41M · Q2 2026
More on Divisadero Street Capital Management, LP
FAQ
How long has Divisadero Street Capital Management, LP held BBNX?
Divisadero Street Capital Management, LP has disclosed BBNX holdings in 3 of the last 5 reported quarters, going back to Q2 2025.
What is Divisadero Street Capital Management, LP's current position in BBNX?
As of Q2 2026, Divisadero Street Capital Management, LP holds 1.11M shares of BBNX (BETA BIONICS INC), valued at $17.45M, representing 0.43% of its reported portfolio and ranking #44.
Has Divisadero Street Capital Management, LP been buying or selling BBNX?
In the latest 13F filing (Q2 2026), Divisadero Street Capital Management, LP newly opened its position in BBNX. The position peaked in Q2 2026 at 1.11M shares.
Which other funds hold BBNX?
Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.